Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2010 2
2012 1
2015 3
2016 8
2017 9
2018 13
2019 17
2020 11
2021 17
2022 10
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study.
Pires da Silva I, Ahmed T, Reijers ILM, Weppler AM, Betof Warner A, Patrinely JR, Serra-Bellver P, Allayous C, Mangana J, Nguyen K, Zimmer L, Trojaniello C, Stout D, Lyle M, Klein O, Gerard CL, Michielin O, Haydon A, Ascierto PA, Carlino MS, Lebbe C, Lorigan P, Johnson DB, Sandhu S, Lo SN, Blank CU, Menzies AM, Long GV. Pires da Silva I, et al. Among authors: mangana j. Lancet Oncol. 2021 Jun;22(6):836-847. doi: 10.1016/S1470-2045(21)00097-8. Epub 2021 May 11. Lancet Oncol. 2021. PMID: 33989557
Sorafenib in melanoma.
Mangana J, Levesque MP, Karpova MB, Dummer R. Mangana J, et al. Expert Opin Investig Drugs. 2012 Apr;21(4):557-68. doi: 10.1517/13543784.2012.665872. Epub 2012 Mar 7. Expert Opin Investig Drugs. 2012. PMID: 22394203 Review.
How I treat metastatic melanoma.
Dummer R, Mangana J, Frauchiger AL, Lang C, Micaletto S, Barysch MJ. Dummer R, et al. Among authors: mangana j. ESMO Open. 2019 Jul 21;4(Suppl 2):e000509. doi: 10.1136/esmoopen-2019-000509. eCollection 2019. ESMO Open. 2019. PMID: 31423341 Free PMC article. Review.
Update on adjuvant melanoma therapy.
Dimitriou F, Braun RP, Mangana J. Dimitriou F, et al. Among authors: mangana j. Curr Opin Oncol. 2018 Mar;30(2):118-124. doi: 10.1097/CCO.0000000000000432. Curr Opin Oncol. 2018. PMID: 29256902 Free article. Review.
Developments in targeted therapy in melanoma.
Amann VC, Ramelyte E, Thurneysen S, Pitocco R, Bentele-Jaberg N, Goldinger SM, Dummer R, Mangana J. Amann VC, et al. Among authors: mangana j. Eur J Surg Oncol. 2017 Mar;43(3):581-593. doi: 10.1016/j.ejso.2016.10.014. Epub 2016 Nov 5. Eur J Surg Oncol. 2017. PMID: 27923592 Free article. Review.
Targeting complex, adaptive responses in melanoma therapy.
Cheng P, Levesque MP, Dummer R, Mangana J. Cheng P, et al. Among authors: mangana j. Cancer Treat Rev. 2020 Jun;86:101997. doi: 10.1016/j.ctrv.2020.101997. Epub 2020 Mar 2. Cancer Treat Rev. 2020. PMID: 32179238 Review.
Electrical Impedance Spectroscopy in Skin Cancer Diagnosis.
Braun RP, Mangana J, Goldinger S, French L, Dummer R, Marghoob AA. Braun RP, et al. Among authors: mangana j. Dermatol Clin. 2017 Oct;35(4):489-493. doi: 10.1016/j.det.2017.06.009. Epub 2017 Aug 7. Dermatol Clin. 2017. PMID: 28886804 Review.
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma.
Bhave P, Ahmed T, Lo SN, Shoushtari A, Zaremba A, Versluis JM, Mangana J, Weichenthal M, Si L, Lesimple T, Robert C, Trojanello C, Wicky A, Heywood R, Tran L, Batty K, Dimitriou F, Stansfeld A, Allayous C, Schwarze JK, Mooradian MJ, Klein O, Mehmi I, Roberts-Thomson R, Maurichi A, Yeoh HL, Khattak A, Zimmer L, Blank CU, Ramelyte E, Kähler KC, Roy S, Ascierto PA, Michielin O, Lorigan PC, Johnson DB, Plummer R, Lebbe C, Neyns B, Sullivan R, Hamid O, Santinami M, McArthur GA, Haydon AM, Long GV, Menzies AM, Carlino MS. Bhave P, et al. Among authors: mangana j. J Immunother Cancer. 2022 Jul;10(7):e004668. doi: 10.1136/jitc-2022-004668. J Immunother Cancer. 2022. PMID: 35793872 Free PMC article.
EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy.
Amaral T, Pop OT, Chatziioannou E, Sinnberg T, Niessner H, Zhao J, Ring SS, Joerger M, Schroeder C, Armeanu-Ebinger S, Cozzio A, Leiter U, Thomas I, Jochum W, Garbe C, Forchhammer S, Levesque M, Mangana J, Hölzel M, Dummer R, Schürch CM, Forschner A, Flatz L. Amaral T, et al. Among authors: mangana j. J Am Acad Dermatol. 2023 Nov;89(5):1072-1074. doi: 10.1016/j.jaad.2023.06.057. Epub 2023 Jul 22. J Am Acad Dermatol. 2023. PMID: 37487833 No abstract available.
Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy.
Bhave P, Hong A, Lo SN, Johnson R, Mangana J, Johnson DB, Dulgar O, Eroglu Z, Yeoh HL, Haydon A, Lodde GC, Livingstone E, Khattak A, Kähler K, Hausschild A, McArthur GA, Menzies AM, Long G, Wang W, Carlino MS. Bhave P, et al. Among authors: mangana j. J Immunother Cancer. 2023 Mar;11(3):e006629. doi: 10.1136/jitc-2022-006629. J Immunother Cancer. 2023. PMID: 36889810 Free PMC article.
99 results